Anti-DCP1B monoclonal antibody

Pre-made anti-DCP1B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DCP1B/DCP1B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0672-Ab-1/ GM-Tg-hg-IP0672-Ab-2Anti-Human DCP1B monoclonal antibodyHuman
GM-Tg-rg-IP0672-Ab-1/ GM-Tg-rg-IP0672-Ab-2Anti-Rat DCP1B monoclonal antibodyRat
GM-Tg-mg-IP0672-Ab-1/ GM-Tg-mg-IP0672-Ab-2Anti-Mouse DCP1B monoclonal antibodyMouse
GM-Tg-cynog-IP0672-Ab-1/ GM-Tg-cynog-IP0672-Ab-2Anti-Cynomolgus/ Rhesus macaque DCP1B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0672-Ab-1/ GM-Tg-felg-IP0672-Ab-2Anti-Feline DCP1B monoclonal antibodyFeline
GM-Tg-cang-IP0672-Ab-1/ GM-Tg-cang-IP0672-Ab-2Anti-Canine DCP1B monoclonal antibodyCanine
GM-Tg-bovg-IP0672-Ab-1/ GM-Tg-bovg-IP0672-Ab-2Anti-Bovine DCP1B monoclonal antibodyBovine
GM-Tg-equg-IP0672-Ab-1/ GM-Tg-equg-IP0672-Ab-2Anti-Equine DCP1B monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0672-Ab-1/ GM-Tg-hg-IP0672-Ab-2; GM-Tg-rg-IP0672-Ab-1/ GM-Tg-rg-IP0672-Ab-2;
GM-Tg-mg-IP0672-Ab-1/ GM-Tg-mg-IP0672-Ab-2; GM-Tg-cynog-IP0672-Ab-1/ GM-Tg-cynog-IP0672-Ab-2;
GM-Tg-felg-IP0672-Ab-1/ GM-Tg-felg-IP0672-Ab-2; GM-Tg-cang-IP0672-Ab-1/ GM-Tg-cang-IP0672-Ab-2;
GM-Tg-bovg-IP0672-Ab-1/ GM-Tg-bovg-IP0672-Ab-2; GM-Tg-equg-IP0672-Ab-1/ GM-Tg-equg-IP0672-Ab-2
Products NameAnti-DCP1B monoclonal antibody
Formatmab
Target NameDCP1B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DCP1B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0672-Ag-1Recombinant multi-species DCP1B/ DCP1 protein


    Target information

    Target IDGM-IP0672
    Target NameDCP1B
    Gene ID196513,319618,500305,708089,477734,101085048,514548,100055722
    Gene Symbol and SynonymsB930050E02Rik,DCP1,DCP1B,RGD1562214
    Uniprot AccessionQ8IZD4,Q3SZL6
    Uniprot Entry NameDCP1B_HUMAN,DCP1B_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000151065
    Target ClassificationN/A

    The target: DCP1B, gene name: DCP1B, also named as DCP1. This gene encodes a member of a family of proteins that function in removing the 5' cap from mRNAs, which is a step in regulated mRNA decay. This protein localizes to cytoplasmic foci which are the site of mRNA breakdown and turnover. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.